Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$340K
Filings
30
Firms Hired
2
Active Period
2004–2010
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
American Samoa Possession Tax Credit Act of 2003
2008 · fourth_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S 3125, S 2886, S 3335
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1424
Alternative Minimum Tax and Extenders Tax Relief Act of 2008
2008 · fourth_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S 3125, S 2886, S 3335
Client expense: $20,000 · Firm income: —
Matched citations: S 2886
Energy Independence and Tax Relief Act of 2008
2008 · fourth_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S 3125, S 2886, S 3335
Client expense: $20,000 · Firm income: —
Matched citations: S 3125
Jobs, Energy, Families, and Disaster Relief Act of 2008
2008 · fourth_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S 3125, S 2886, S 3335
Client expense: $20,000 · Firm income: —
Matched citations: S 3335
American Samoa Possession Tax Credit Act of 2003
2008 · fourth_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1424
Alternative Minimum Tax and Extenders Tax Relief Act of 2008
2008 · fourth_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $10,000
Matched citations: S. 2886
Medicare Improvements for Patients and Providers Act of 2008
2008 · fourth_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Formulary requirements for certain classes of drugs. S. 3101
Client expense: — · Firm income: $10,000
Matched citations: S. 3101
Energy Independence and Tax Relief Act of 2008
2008 · fourth_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $10,000
Matched citations: S. 3125
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
2008 · fourth_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Implementation of national strategy to prepare for pandemic influenza. FY 2009 Labor, HHS appropriations bill S.3230
Client expense: — · Firm income: $10,000
Matched citations: S.3230
Jobs, Energy, Families, and Disaster Relief Act of 2008
2008 · fourth_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $10,000
Matched citations: S. 3335
American Samoa Possession Tax Credit Act of 2003
2008 · third_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S. 3125, S 2886, S 3335
Client expense: $60,000 · Firm income: —
Matched citations: H.R. 1424
Alternative Minimum Tax and Extenders Tax Relief Act of 2008
2008 · third_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S. 3125, S 2886, S 3335
Client expense: $60,000 · Firm income: —
Matched citations: S 2886
Medicare Improvements for Patients and Providers Act of 2008
2008 · third_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Formulary requirements for certain classes of drugs. s 3101
Client expense: $60,000 · Firm income: —
Matched citations: s 3101
Energy Independence and Tax Relief Act of 2008
2008 · third_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S. 3125, S 2886, S 3335
Client expense: $60,000 · Firm income: —
Matched citations: S. 3125
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
2008 · third_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Implementation of national strategy to prepare for pandemic influenza FY 2009 Labor, HHS appropriations bill - S. 3230
Client expense: $60,000 · Firm income: —
Matched citations: S. 3230
Jobs, Energy, Families, and Disaster Relief Act of 2008
2008 · third_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 H.R. 1424 S. 3125, S 2886, S 3335
Client expense: $60,000 · Firm income: —
Matched citations: S 3335
American Samoa Possession Tax Credit Act of 2003
2008 · third_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1424
Alternative Minimum Tax and Extenders Tax Relief Act of 2008
2008 · third_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $20,000
Matched citations: S. 2886
Medicare Improvements for Patients and Providers Act of 2008
2008 · third_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Formulary requirements for certain classes of drugs. S. 3101
Client expense: — · Firm income: $20,000
Matched citations: S. 3101
Energy Independence and Tax Relief Act of 2008
2008 · third_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $20,000
Matched citations: S. 3125
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
2008 · third_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Implementation of national strategy to prepare for pandemic influenza. FY 2009 Labor, HHS appropriations bill S.3230
Client expense: — · Firm income: $20,000
Matched citations: S.3230
Jobs, Energy, Families, and Disaster Relief Act of 2008
2008 · third_quarter · Firm: VORYS, SATER, SEYMOUR AND PEASE LLP
Extension of the research and development tax credit. H.R. 6049, H.R. 1424 S. 3125, S. 2886, S. 3335
Client expense: — · Firm income: $20,000
Matched citations: S. 3335
Alternative Minimum Tax and Extenders Tax Relief Act of 2008
2008 · second_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 S. 3125 S 2886
Client expense: $60,000 · Firm income: —
Matched citations: S 2886
Medicare Improvements for Patients and Providers Act of 2008
2008 · second_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Formulary requirements for certain classes of drugs. S. 3101
Client expense: $60,000 · Firm income: —
Matched citations: S. 3101
Energy Independence and Tax Relief Act of 2008
2008 · second_quarter · Firm: SOLVAY PHARMACEUTICALS, INC.
Extension of the research and development tax credit H.R. 6049 S. 3125 S 2886
Client expense: $60,000 · Firm income: —
Matched citations: S. 3125
Source: Senate LDA